To own Enact Holdings, you need to believe that steady but slower mortgage insurance demand can still support a solid, risk aware underwriting franchise, even if mortgage volumes and earnings forecasts look flat to slightly softer. The 2028 quota share reinsurance move fits that mindset. It speaks more to long term risk distribution than to any dramatic shift in near term earnings expectations.
Right now, the swing factor remains how credit performance and housing trends evolve against modest revenue growth assumptions and low double digit return on equity. The key risk is that weak originations and tougher pricing compress earnings more quickly than expected. The 2028 quota share decision does not materially change that short term risk reward balance.
The most relevant recent development is Enact Holdings' ongoing capital and risk management posture, including its focus on diversified credit risk transfer. The 2028 quota share reinsurance agreement extends that playbook by sharing a defined slice of new insurance written with external reinsurers. That keeps future capital needs and loss volatility more predictable around that 2028 book year.
For catalysts, this matters because a smoother loss profile and clearer capital path can influence how comfortably Enact runs its P/E driven valuation story, how it supports dividends and how it considers buybacks when conditions allow. On the flip side, heavy use of reinsurance can cap upside from any favourable claim outcomes, so investors need to weigh that trade off against the benefit of reduced tail risk.
Enact Holdings' current earnings are about US$683.3 million, with analyst consensus pointing to roughly flat revenue and profit margins easing over time, and earnings of US$661.8 million by 2029. That forecast implies revenues of about US$1.3 billion and an earnings decline of US$21.5 million by the 2029 estimate year compared with earnings today.
Uncover why Enact Holdings' fair value indicates an 11% potential upside to its current price that may not last much longer.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider doing your own research.
Once you have a view on Enact Holdings, it can help to place that thesis alongside other opportunities with different risk and income profiles. The Simply Wall St Screener lets you line up a wide range of listed businesses and filter them by balance sheet strength, dividends or valuation so you can see where Enact fits in your broader portfolio plan.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com